Deborah Morosini, EVP, Chief of Clinical Affairs at Prelude Therapeutics Inc (PRLD), sold 28,751 shares at $13.00 ($374K) on 2021-12-15, disclosed to the SEC on 2021-12-17.
Open-market sale of $374k PRLD by EVP, Chief of Clinical Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PRLD | SELL | 2021-04-15 | $4K | — | Filing → |
| PRLD | SELL | 2021-04-09 | $40K | — | Filing → |
| PRLD | BUY | 2020-09-29 | $8K | — | Filing → |